Sahar Mokhles|A.P.W.M. Maat|Joachim Aerts|Joost J. Nuyttens|Ad J.J.C. Bogers|Johanna J.M. Takkenberg
Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer†
Erasmus University Rotterdam|Erasmus MC|Erasmus University Rotterdam|Erasmus MC|Erasmus University Rotterdam|Erasmus MC|Erasmus MC Cancer Institute|Erasmus University Rotterdam|Erasmus MC|Erasmus University Rotterdam|Erasmus MC
investigate opinions lung cancer clinicians concerning shared decision making sdm earlystage nonsmallcell lung cancer patientsa survey conducted among dutch cardiothoracic surgeons lung surgeons pulmonologists radiation oncologists opinions clinicians involvement patients treatment decision making assessed using 15 likerttype scale open questions queried barriers drivers sdm clinical practice clinicians asked review 7 hypothetical cases indicate treatment strategy would choose using 17 likerttype scaletwentysix percent surgeons 20 pulmonologists 12 radiation oncologists indicated always engage sdm 16 missing pvalue 010 respondents stated ideally doctors patients decide together surgeons 52 pulmonologists 67 radiation oncologists 35 pvalue 0005 thirty percent surgeons 27 pulmonologists 44 radiation oncologists indicated doctors properly trained implement sdm clinical practice pvalue 037 sdm may always feasible due low patient education level minimal knowledge lung cancer wide variations clinicians lung cancer treatment preferences observed responses hypothetical casesin current clinical decision making lung cancer treatment majority clinicians agree important involve lung cancer patients treatment decision making time constraints inability patients make weighted decision important barriers observed variation lung cancer treatment preferences among clinicians suggests patients surgery radiotherapy suitable options underlines sensitive nature treatment choices earlystage nonsmallcell lung cancer